BioInformant

Your Global Leader in Stem Cell Market Research

MENUMENU
  • Blog
    • Interviews
  • News
  • Stem Cells
    • iPS Cells
    • MSCs
    • HSCs
    • Adipose SCs
    • Neural Stem Cells
  • Exosomes
  • CAR-T
  • Cord Blood
  • Shop
    • Products
    • Submit PR
    • Advertise
  • About
    • Testimonials
    • Story
    • Guarantee
    • Contact
  • Home
  • Blog
    • Stem Cells
      • HSCs
      • iPS Cells
      • MSCs
      • Neural Stem Cells
      • Adipose SCs
    • Exosomes
    • Cell Therapy
      • CAR-T
    • Cord Blood
    • Stem Cell News
    • Interviews
  • COVID-19
  • Shop
  • Submit PR
  • Company
    • Advertise
    • Testimonials
    • Story
    • Job Posts
    • Guarantee
    • Privacy Policy
    • Contact
Home » women's health

Next Biosciences and Genesis Genetics Combine to Consolidate Stem Cell Banking and Genetic Testing within Africa

May 17, 2016 By Cade Hildreth (CEO) Leave a Comment

Next Biosciences and Genesis Genetics South Africa Combine their DNA - Depositphotos_55245169_m-2015.jpg

Based in South Africa, Next Biosciences is a unique company.  It owns Netcells, Africa’s largest private stem cell bank. It also recently merged with a local laboratory, Genesis Genetics, making Next Biosciences the only facility on the African continent to offer genetic and metabolic screening, as well as storage of umbilical cord blood and tissue for use in regenerative medicine applications.

As such, Next Biosciences plays a leading role within the South African cord blood banking marketplace and operates within genetic and metabolic screening markets.

To learn more about Next Biosciences and its recent merger with Genesis Genetics South Africa, read the company press release below, printed with permission from the company’s Public Relations advisor, Gina de Villiers. 


Next Biosciences and Genesis Genetics South Africa Combine their DNA

Merger of local leaders in stem cell banking and genetic testing consolidate their position
in African biotechnology industry

Johannesburg, 17 May 2016 — Next Biosciences, a South African leader in stem cell banking, and Genesis Genetics South Africa, the local provider of internationally pioneered genetic technology, have merged to consolidate their position in South Africa’s burgeoning biotechnology industry. As a result, Genesis Genetics South Africa becomes a Next Biosciences company.

The new Next Biosciences group of companies owns Netcells, Africa’s largest private stem cell bank. This is now the only such facility on the continent to offer genetic and metabolic screening as well as storage of umbilical cord blood and tissue for use in various regenerative medical therapies. [Read more…]

Filed Under: Press Releases, Stem Cells Tagged With: biotechnology, cord blood, Genesis Genetics, Netcells, Next Biosciences, regenerative medicine, South Africa, stem cell bank, stem cells, women's health

Nanocellect

Marathon Products

Let’s Get Social

  • Facebook
  • Twitter
  • LinkedIn
  • Pinterest
  • Instagram
Menu
  • Blog
  • Stem Cell News
    • Press Releases
  • Stem Cells
    • HSCs
    • iPS Cells
    • MSCs
    • Neural Stem Cells
    • Adipose SCs
  • Exosomes
  • Cell Therapy
    • CAR-T
  • Cord Blood
  • Interviews

Cart

Top Rated Products

  • Job Posting on BioInformant Job Posting on BioInformant.com - Your Perfect Hire Is In Our Audience
    Rated 0 out of 5
    $297
  • U.S. Cord Blood Banking Survey Cord Blood Banking Survey of U.S. Parents [2017]
    Rated 0 out of 5
    $197
  • Exosome Companies 2020 Global Database of Exosome Companies
    Rated 0 out of 5
    $149 $97
My Tweets

BioInformant's World-Class Clients

  • Submit Press Release
  • Advertise
  • Privacy and Terms

Copyright © 2022 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: Info@BioInformant.com | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.